(ANSA) – BEIJING, AUGUST 17 – China has given its first approval to a possible vaccine against Covid-19: it is Ad5-nCoV, developed by CanSino Biologics with the Biotechnology Institute of the Academy of Medical Sciences military.
The green light paves the way for possible mass production quickly in the event of a return of the pandemic, explained the China National Intellectual Property Administration, cited by the state network CCTV. The approval, received on 11 August last but only now known, “is further confirmation of the efficacy and safety” of the developed product, the Tianjin group said in a statement, whose titles have meanwhile recorded substantial increases in the stock market. (HANDLE).
news-copy”>REPRODUCTION RESERVED © Copyright ANSA